[Differentiated pathogenetic therapy of glomerulonephritis].
N
N
Belovezhdov
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use*; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D002908:Chronic Disease; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000209:etiology; D005922:Glomerulonephritis, IGA / Q000188:drug therapy; D005923:Glomerulosclerosis, Focal Segmental / Q000188:drug therapy; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008775:Methylprednisolone / Q000627:therapeutic use; D009402:Nephrosis, Lipoid / Q000188:drug therapy; D011239:Prednisolone / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000925:Anticoagulants; D007166:Immunosuppressive Agents; D006493:Heparin; D011239:Prednisolone; D001379:Azathioprine; D008775:Methylprednisolone
Differentsirovannoe patogeneticheskoe lechenie glomerulonefritov.